Cassava Sciences is a clinical-stage drug development company. The company focuses on developing new product candidates and to guide these through various regulatory and development pathways in preparation for their potential commercialization. The company's clinical-stage biopharmaceutical assets include: PTI-125, which is its product candidate for the treatment of Alzheimer's disease; and PTI-125Dx, which it is developing as a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company owns worldwide rights to PTI-125 and PTI-125Dx, without royalty obligations to any third party.

First Guaranty Bancshares is a bank holding company. The company, through its subsidiary, First Guaranty Bank (the Bank), provides a range of financial services to consumers and businesses in the communities in which it operates. These services include consumer and commercial lending, mortgage loan origination, the issuance of credit cards and retail banking services. The Bank also maintains an investment portfolio comprised of government, government agency, corporate, and municipal securities. The company's key market areas include the Louisiana Market Services Areas (MSAs) of Hammond, Baton Rouge, Lafayette, and Shreveport-Bossier City along with the Texas MSAs of Dallas-Fort Worth-Arlington and Waco.

First Savings Financial Group is a financial holding company. Through its subsidiary, First Savings Bank, the company provides financial services to consumers and businesses in its primary market area. The company accepts deposits from the general public and uses those funds to originate primarily residential and commercial mortgage loans. The company also originates commercial business loans, residential and commercial construction loans, multi-family loans, land and land development loans, and consumer loans. The company considers Clark, Floyd, Harrison, Crawford, Washington and Daviess counties, IN, in which all of its offices are located, and the surrounding areas to be its primary market area.